Suppr超能文献

相似文献

2
Sequential activation of protein kinase C delta and JNK is required for interferon-alpha-induced expression of IFIT4.
Cell Signal. 2008 Jan;20(1):112-9. doi: 10.1016/j.cellsig.2007.08.020. Epub 2007 Sep 26.
5
Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus.
J Clin Immunol. 2011 Jun;31(3):369-78. doi: 10.1007/s10875-010-9496-0. Epub 2010 Dec 29.
9
Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
PLoS One. 2013 Dec 31;8(12):e83776. doi: 10.1371/journal.pone.0083776. eCollection 2013.

引用本文的文献

2
Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Front Immunol. 2022 Jul 28;13:962393. doi: 10.3389/fimmu.2022.962393. eCollection 2022.
3
Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus.
Front Immunol. 2022 Jun 9;13:844025. doi: 10.3389/fimmu.2022.844025. eCollection 2022.
4
Mouse Ifit1b is a cap1-RNA-binding protein that inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c.
J Biol Chem. 2020 Dec 18;295(51):17781-17801. doi: 10.1074/jbc.RA120.014695. Epub 2020 Oct 19.
6
Common Marker Genes Identified from Various Sample Types for Systemic Lupus Erythematosus.
PLoS One. 2016 Jun 3;11(6):e0156234. doi: 10.1371/journal.pone.0156234. eCollection 2016.
7
Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells.
J Immunol Res. 2016;2016:6269157. doi: 10.1155/2016/6269157. Epub 2016 Feb 29.
8
Interferon receptor signaling in malignancy: a network of cellular pathways defining biological outcomes.
Mol Cancer Res. 2014 Dec;12(12):1691-703. doi: 10.1158/1541-7786.MCR-14-0450. Epub 2014 Sep 12.
10
Activation of innate immune responses in the central nervous system during reovirus myelitis.
J Virol. 2012 Aug;86(15):8107-18. doi: 10.1128/JVI.00171-12. Epub 2012 May 23.

本文引用的文献

1
Sequential activation of protein kinase C delta and JNK is required for interferon-alpha-induced expression of IFIT4.
Cell Signal. 2008 Jan;20(1):112-9. doi: 10.1016/j.cellsig.2007.08.020. Epub 2007 Sep 26.
2
Type I interferon as a target of treatment in SLE.
Endocr Metab Immune Disord Drug Targets. 2006 Dec;6(4):323-30. doi: 10.2174/187153006779025702.
3
Syndromes and complications of interferon therapy.
Curr Opin Rheumatol. 2007 Jan;19(1):61-6. doi: 10.1097/BOR.0b013e328010c547.
4
RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins.
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16448-53. doi: 10.1073/pnas.0607830103. Epub 2006 Oct 18.
5
Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
Immunity. 2006 Sep;25(3):383-92. doi: 10.1016/j.immuni.2006.08.010.
9
Interferon alpha and its contribution to autoimmunity.
Curr Opin Investig Drugs. 2006 May;7(5):451-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验